Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

369
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

123
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

ATYPICAL HEMOLYTIC-UREMIC SYNDROME THE INTERPLAY BETWEEN COMPLEMENTS AND THE COAGULATION SYSTEM (REVIEW)

Pages

  340-345

Abstract

 Hemolytic-uremic syndrome (HUS) is a rare life-threatening disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, and impaired renal function. A thrombotic microangiopathy underlies the clinical features of HUS. In the majority of cases, HUS follows an infection with toxin-producing bacteria such as verotoxin-producing Escherichia coli. In some cases, HUS is not preceded by a clinically apparent infection, and therefore, is named atypical HUS. The prognosis of atypical HUS is poor. While mortality approaches 25% during the acute phase, endstage renal disease develops in nearly half of patients within a year. Evidence is accumulating that complement activation through the alternative pathway is at the heart of the pathophysiology leading to atypical HUS. Genetic abnormalities involving complement regulatory proteins and complement components form the molecular basis for complement activation. Since microvascular thrombosis is a quintessential feature of atypical HUS, complements and the coagulation system must work in tandem to give rise to the pathologic alterations observed in this condition. Here, a brief discussion of clinical and morphologic features of atypical HUS is followed by a concise presentation of the complement and coagulation systems. The interplay between complements and the coagulation system is graphically highlighted. Last but not least, conventional and emerging therapies for atypical HUS are outlined.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    NAYER, ALI, & ASIF, ARIF. (2013). ATYPICAL HEMOLYTIC-UREMIC SYNDROME THE INTERPLAY BETWEEN COMPLEMENTS AND THE COAGULATION SYSTEM (REVIEW). IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), 7(5), 340-345. SID. https://sid.ir/paper/309442/en

    Vancouver: Copy

    NAYER ALI, ASIF ARIF. ATYPICAL HEMOLYTIC-UREMIC SYNDROME THE INTERPLAY BETWEEN COMPLEMENTS AND THE COAGULATION SYSTEM (REVIEW). IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD)[Internet]. 2013;7(5):340-345. Available from: https://sid.ir/paper/309442/en

    IEEE: Copy

    ALI NAYER, and ARIF ASIF, “ATYPICAL HEMOLYTIC-UREMIC SYNDROME THE INTERPLAY BETWEEN COMPLEMENTS AND THE COAGULATION SYSTEM (REVIEW),” IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), vol. 7, no. 5, pp. 340–345, 2013, [Online]. Available: https://sid.ir/paper/309442/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top